BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488,754 | +61.3% | 69,033 | +187.2% | 0.01% | +11.1% |
| Q3 2022 | $303,000 | +27.8% | 24,034 | +65.2% | 0.01% | +28.6% |
| Q1 2022 | $237,000 | +51.0% | 14,548 | +28.7% | 0.01% | +40.0% |
| Q4 2021 | $157,000 | -79.6% | 11,308 | -76.8% | 0.01% | -84.8% |
| Q2 2021 | $769,000 | +605.5% | 48,641 | +231.8% | 0.03% | +725.0% |
| Q4 2020 | $109,000 | +127.1% | 14,658 | +5.0% | 0.00% | +100.0% |
| Q3 2020 | $48,000 | -33.3% | 13,964 | -7.8% | 0.00% | 0.0% |
| Q2 2020 | $72,000 | +26.3% | 15,140 | -46.6% | 0.00% | 0.0% |
| Q1 2020 | $57,000 | -94.6% | 28,368 | -77.6% | 0.00% | -84.6% |
| Q1 2017 | $1,063,000 | +431.5% | 126,553 | +551.5% | 0.01% | +550.0% |
| Q4 2015 | $200,000 | – | 19,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |